Recent Posts by Labion

Report AXA Italia

Recently, AXA has published a report of Corporate Responsibility 2014. We have participated in the preparation of the chapter about the calculation of SROI, as one of the beneficiaries of funding for projects destined to the young generation. In fact, AXA Italia has decided to calculate the impact of the investments  in...
Read more

Giornale di Brescia writes on Labion

Yesterday, Giornale di Brescia dedicated an article titled "Nanomedicina e Biofotonica: il Futuro" (Nanomedicine and Biophotonics: the future) to the Labion activities on nanomedicine. In particular the articles is focused on our participation as founding member to the European Technology Platform Nanomedicine (ETPN) an initiative set up by industries and...
Read more

LABION contributed to BioPhotonics 2015

LABION recently contributed to BioPhotonics2015, the international conference on biophotonics organized by the Institute of Electrical and Electronics Engineers (IEEE). Dr. Renzo Vanna presented new approaches based on label-free Raman imaging for the study of nanocarriers and graphene at intracellular level without the use of antibodies of other markers. Oral Presentation entitled "Raman Imaging...
Read more

Cream Formulation for Nanoparticles Topical Administration

A new article has been recently published by Labion on “PlosOne” about the development of nano-cream for the rapid targeting of bioactive agents in the skin barrier and comprises significant results derived from the successful and long-lasting collaboration between Fondazione Don Gnocchi and the University of Milano-Bicocca.   Read more

CERCHIAMO TESISTI

CERCHIAMO TESISTI: studenti iscritti a corsi di laurea in Biotecnologie, Biologia, CTF o Ingegneria biomedica che siano interessati alle nanotecnologie, alla biochimica, alla biologia molecolare, alla chimica analitica, ai metodi biofisici e a un approccio di ricerca multidisciplinare e applicato all'ambito clinico. - PROPOSTA DI TIROCINIO PER TESI SPERIMENTALE “ESTERNA” – Temi trattati:
  • microRNA, Nanotecnologie e Biofotonica per...
Read more

Call for paper: Updates in Personalized Treatment

Labion participates to the preparation of a special issue of Biomed. Res. Int. on the impact of nanotechnology on personalized treatments. A clear shift is occurring in medicine. Molecularly targeted therapies opened the era of "personalized medicine” which, in its simplest definition, consists in administering the right drug to the right patient at the right moment....
Read more

RAMAN SPECTROSCOPY FOR THE DIAGNOSIS OF LEUKEMIA: A STEP FORWARD

A new article, recently published by "Analyst" (RSC), emerged from the collaboration between LABION (Fond. Don Gnocchi), Dott. Fabio Ciceri (Ospedale San Raffaele IRCCS) and Prof. Cees Otto (Twente University, The Netherlands) and demonstrated the possibility to distinguish different leukemia cells by using label-free Raman spectroscopy. Analyst News Read more

LABION Researcher granted by Fondazione Umberto Veronesi

Dr. Alice Gualerzi has been granted by Fondazione Umberto Veronesi with a 12-month-long Post-doctoral Fellowship to work on a project entitled: INNOVATIVE NON-INVASIVE RAMAN APPROACH FOR EARLY DIAGNOSIS OF SKIN CANCER. Taking advantage of her background in morphology and previous research experience in the field of epithelial basic research, Dr. Gualerzi is going to work on...
Read more

Recent Comments by Labion

    No comments by Labion yet.